E. Perticucci

Role of remission clinics in the longitudinal treatment of CKD.

G. Remuzzi, Sanjib K. Sharma, P. Ruggenenti, 2008, Journal of the American Society of Nephrology : JASN.

Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy.

G. Remuzzi, A. Remuzzi, P. Ruggenenti, 1991, Kidney international.

Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies.

G. Remuzzi, A. Remuzzi, P. Ruggenenti, 2003, Kidney international.

Low-protein diet and glomerular size-selective function in membranous glomerulopathy.

G. Remuzzi, A. Remuzzi, G. D'Amico, 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial.

G. Remuzzi, C. Zoccali, M. Trillini, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Acidemia alone does not stimulate rat renal Na+-H+ antiporter activity.

T. E. Northrup, J. Cohen, E. Perticucci, 1988, The American journal of physiology.

Supranormal von Willebrand factor multimers in scleroderma.

G. Remuzzi, P. Mannucci, R. Lombardi, 1989, Blood.

Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial

G. Remuzzi, B. Ene-Iordache, P. Ruggenenti, 2005, The Lancet.

Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophil activation.

G. Remuzzi, M. Morigi, D. Cattaneo, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Role of remission clinics in the longitudinal treatment of CKD.

G. Remuzzi, P. Ruggenenti, A. Perna, 2008, Journal of the American Society of Nephrology : JASN.